Omberacetam

Common card · No. 314161

Omberacetam, also known as N-phenylacetyl-l-prolylglycine ethyl ester, is promoted as a nootropic and is a prodrug of cyclic glycine-proline. Other names include the brand name Noopept (Russian: Ноопепт), developmental code GVS-111. Its synthesis was first reported in 1996. It is orally available. As of 2017, its metabolism and elimination half-life in humans were not well understood. It has been evaluated for neuroprotective effects in treating brain injuries and stroke.

Read on Wikipedia · Image Benrr101, CC0